Lilly's $3.8 Billion Vaccine Bets: A Quiet Shift Now
Lilly's heavy reliance on GLP-1 drugs has investors watching as the company bets $3.8B on vaccines. This analysis exp...
Index values follow a defined daily schedule so investors know when to expect updates. This brief explains the publication times and how to use the data in your investing routine.
21,512 articlesLilly's heavy reliance on GLP-1 drugs has investors watching as the company bets $3.8B on vaccines. This analysis exp...
SpaceX confirms Dogecoin as payment for a lunar mission, reviving meme coin chatter as DOGE trades within a tight ran...
As kickoff nears, hundreds of tickets for the U.S. opener sit unsold, while resale platforms show discounted options....
Adobe is expected to announce its next chief executive on Thursday, with the board leaning toward an internal candida...
Meta is weighing a large primary equity offering to fund an aggressive AI buildout as costs rise. Analysts warn dilut...
The market has been pushing toward higher rates, and the phrase uh-oh! probability fomc rate is popping up in convers...
Markets surge as investors debate mega-valuations tied to founder-led tech giants. This piece breaks down what everyd...
Chewy has shown growth in revenue alongside margin pressures as it scales its e-commerce pet-products platform. This ...
A long-running dividend payer with 70 straight years of increases is drawing buyers as its stock dips. The company pl...
AMD jumps record high as chip stocks surge on AI demand and risk appetite. NVIDIA and Intel join the climb, signaling...
Archer Aviation advances toward FAA Type Certification, with a looming Texas governance vote and a quarterly report t...
Investing in AI stocks can feel like a fast-moving target. This article breaks down whether penguin solutions next st...